| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 05/02/2006 | US7037920 Substituted tricyclic himbacine derivatives that are useful as thrombin receptor antagonists |
| 05/02/2006 | US7037919 novel nonsteroidal compounds and salts; have a specific and strong binding affinity for androgen receptors and exhibit AR agonism or antagonism; therapeutic effect on AR-mediated diseases such as male hypogonadism, male sexual dysfunction, anemia, aids, breast, prostate cancer |
| 05/02/2006 | US7037912 Enzyme inhibitor contains two or more ligand moieties comprising pyrimidinyl groups covalently linked together by linking groups; keratitis, diabetic retinopathy, angiogenesis, vision defects, ischemia, atherosclerosis,psoriasis, cancer, cirrhosis, diabetes, arthritis, autoimmune disease |
| 05/02/2006 | US7037907 Prodrug of an estradiol conjugated to a glucuronide sugar; 6-oxo-2-methoxyestradiol; 3-acetyl-6-oxo-2-methoxyestradiol; and 2-methoxyestradiol-6-hydrazone; angiogenesis inhibitor; antiinflammatory for asthma or rheumatoid arthritis |
| 05/02/2006 | US7037899 Derivatives of 2-3-O- isopropylidene- alpha -L-xylo-2-hexulofuranosonic acid, useful for treating inflammatory and autoimmune diseases |
| 05/02/2006 | US7037896 HIV inhibiting peptide (VIRIP) and amidated, acetylated, sulfated, polyethylene glycol modified, phosphorylated and/or glycosylated derivatives |
| 05/02/2006 | US7037701 Genetic engineering; detection moderators of kinase peptidespeptides |
| 05/02/2006 | US7037666 Contacting latency-associated peptide- beta 1 (LAP- beta 1) or a functional variant thereof and integrin alpha v beta 3 or a functional variant thereof with test product under conditions that, in absence of test product, would permit interaction |
| 05/02/2006 | US7037665 Compositions comprising SNORF36 receptor compounds |
| 05/02/2006 | CA2334012C 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors |
| 04/27/2006 | WO2006044961A1 Ppar-gamma modulatores |
| 04/27/2006 | WO2006044451A1 Treatment of osteoarthritis and dosing regimen for arzoxifene |
| 04/27/2006 | WO2006044412A1 Novel b1 bradykinin receptor antagonists |
| 04/27/2006 | WO2006043722A1 Chimeric (double) decoy |
| 04/27/2006 | WO2006043671A1 TRANSCRIPTIONAL FACTOR Nrf2 ACTIVATOR AND FOOD HAVING THE FUNCTION OF THE SAME IMPARTED THERETO |
| 04/27/2006 | WO2006043515A1 Pyrimidine-5-carboxylic acid derivative |
| 04/27/2006 | WO2006023396A3 Vla-4 antagonists |
| 04/27/2006 | WO2006021660A8 Use of at least one conjugated triene-containing fatty acid for preparing a medicine for treating inflammation |
| 04/27/2006 | WO2006003388A3 Compositions and methods for treating inflammatory disorders |
| 04/27/2006 | WO2005025603A3 Methods of using wisp antagonists |
| 04/27/2006 | US20060089401 Kinase inhibitors |
| 04/27/2006 | US20060089393 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 04/27/2006 | US20060089353 Indole derivative compounds and drugs containing the compounds as the active ingredient |
| 04/27/2006 | US20060089345 Indole derivatives, method for preparating same and pharmaceutical compositions containing same |
| 04/27/2006 | US20060089334 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 04/27/2006 | US20060089326 Immunostimulatory nucleic acid molecules |
| 04/27/2006 | US20060089312 Protease inhibitors |
| 04/27/2006 | US20060088890 Identification and isolation of somatic stem cells and uses thereof |
| 04/27/2006 | US20060088580 Hormone-containing transdermal therapeutic system with an active substance reservoir based on vinylacetate-vinylpyrrolidone copolymer with improved cohesion |
| 04/27/2006 | US20060088565 Device having osteoinductive and osteoconductive properties |
| 04/27/2006 | US20060088540 Antagonists and methods for inhibiting angiogenesis |
| 04/27/2006 | US20060088508 Method for obtaining characterized muscle-derived cell populations and uses |
| 04/27/2006 | CA2584747A1 Treatment of osteoarthritis and dosing regimen for arzoxifene |
| 04/27/2006 | CA2584041A1 Biphenyl integrin antagonists |
| 04/27/2006 | CA2583576A1 Chimera (double) decoy |
| 04/27/2006 | CA2583267A1 Novel b1 bradykinin receptor antagonists |
| 04/26/2006 | EP1650312A2 Functional assay of high-density lipoprotein |
| 04/26/2006 | EP1650210A1 Therapeutic agent for hyperpotassemia and bone disease |
| 04/26/2006 | EP1650205A1 Cyclohexanecarboxylic acid compound |
| 04/26/2006 | EP1650204A1 Process for producing 1,2,4-triazole compound and intermediate therefor |
| 04/26/2006 | EP1650201A1 Benzoxazepine compound |
| 04/26/2006 | EP1650199A1 Sulfonamide derivative having isoxazole ring |
| 04/26/2006 | EP1650193A2 6-Phenylphenanthridines with PDE-IV inhibiting activity |
| 04/26/2006 | EP1649872A1 Sheet for guiding regeneration of mesenchymal tissue and production method thereof |
| 04/26/2006 | EP1649865A1 Use of osteogenic proteins for the preparation of a pharmaceutical composition for repairing a defect locus in a non articular cartilage tissue of a mammal |
| 04/26/2006 | EP1649760A1 Composition containing lactic acid bacterium producing equol |
| 04/26/2006 | EP1649758A1 Masticatable capsule and process for producing the same |
| 04/26/2006 | EP1648494A2 Novel anti-angiogenetic agent and its use, in particular in cancer treatment |
| 04/26/2006 | EP1648486A2 Use of a pak inhibitor for the treatment of a joint disease |
| 04/26/2006 | EP1648482A2 Use of a cosmetic or pharmaceutical composition, comprising a lupeol-rich extract as an active ingredient for stimulating the synthesis of heat shock proteins |
| 04/26/2006 | EP1648479A2 Therapeutic use of lipids extracted from mother of pearl |
| 04/26/2006 | EP1648437A2 Sirt1 modulators for manipulating cell/organism lifespan/stress response |
| 04/26/2006 | EP1421377B1 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 04/26/2006 | EP1414802B1 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 04/26/2006 | EP1409485B1 Immunomodulating compounds |
| 04/26/2006 | EP1309592B1 Substituted pyrazoles |
| 04/26/2006 | EP1244702B1 Process for isolation of osteopontin from milk |
| 04/26/2006 | EP1210348B9 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 04/26/2006 | CN1764670A Compound having affinity with calcified tissue |
| 04/26/2006 | CN1764655A Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 04/26/2006 | CN1764465A Remedy or preventive for low turnover bone diseases |
| 04/26/2006 | CN1764456A Treatment of diseases with alpha-7nACh receptor full agonists |
| 04/26/2006 | CN1764454A Cyclic protein tyrosine kinase inhibitors |
| 04/26/2006 | CN1762479A Externally applied medicine of stahlianthus involucratus |
| 04/26/2006 | CN1762472A Hemiphragma heterophyllum wall wine for injury |
| 04/26/2006 | CN1762469A Externally applied medicine of madeira vine |
| 04/26/2006 | CN1762468A Leatherleaf milletia wine for traumatic injury |
| 04/26/2006 | CN1762464A Externally applied medicine of crescentia cujete L. |
| 04/26/2006 | CN1762463A Externally applied medicine of radix araliae armatae |
| 04/26/2006 | CN1762449A Medicinal wine with Damnacanthus indicus Gaertn.f. for traumatic injury |
| 04/26/2006 | CN1762446A Medicinal wine of Asarum maximum Hemsl. for traumatic injury |
| 04/26/2006 | CN1762445A Medicinal wine for traumatic injury and its preparation method |
| 04/26/2006 | CN1762444A Externally medicine of Aconitun sungpanense Hand -Mazz |
| 04/26/2006 | CN1762443A Rubia root medicinal wine for injury |
| 04/26/2006 | CN1762437A Bolus for treating rheumatic or rheumatoid arthritis and its preparation method |
| 04/26/2006 | CN1762436A Externally applied medicine of Ligularia lapathifolia |
| 04/26/2006 | CN1762435A Red peony root medicinal wine for injury |
| 04/26/2006 | CN1762433A Novel medicinal formula for treating bone fracture and its preparation method |
| 04/26/2006 | CN1762432A Medicinal wine with piper boehmeriaefolium wall for traumatic injury |
| 04/26/2006 | CN1762427A Chinese herbal medicinal plastering agent for treating bone fracture |
| 04/26/2006 | CN1762426A Externally applied medicine of Japanese thistle |
| 04/26/2006 | CN1762418A Celasfl medicinal wine for traumatic injury |
| 04/26/2006 | CN1762414A Externally applied medicine of clematis armandi franch |
| 04/26/2006 | CN1762413A Desmodium caudatum herbal wine for traumatic injury |
| 04/26/2006 | CN1762412A Winterberry euonymus herbal wine for traumatic injury |
| 04/26/2006 | CN1762411A Dendropanax chevalieri herbal wine for traumatic injury |
| 04/26/2006 | CN1762394A Trogopterus dung-containing pain-relieving pill formula and its preparation method |
| 04/26/2006 | CN1762386A Bone density-increasing and senility-postponing capsule formulation |
| 04/26/2006 | CN1762379A Compound glucosamine sulfate dispersible tablet formulation and its preparation method |
| 04/26/2006 | CN1762359A Lindera root alkaloid, its preparation method and application in medicine preparation |
| 04/26/2006 | CN1762355A (imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation |
| 04/26/2006 | CN1762329A Skin-caring nano snake oil skin-care preparation |
| 04/26/2006 | CN1253468C Estrogen-growth hormone release peptide possessing the function of resisting osteoporosis |
| 04/26/2006 | CN1253449C Indolylmaleimide derivatives as protein kinase C inibitors |
| 04/26/2006 | CN1253441C Protease inhibitors |
| 04/26/2006 | CN1253435C Aryl oxime-piperazines useful as CCR5 antagonists |
| 04/26/2006 | CN1253197C Medicine for treating rheumatoid and rheumatic arthritis and preparation method thereof |
| 04/26/2006 | CN1253180C Externally applied Chinese medicinal plaster for treating bone pain |
| 04/26/2006 | CN1253179C Drug for treating ischemic necrosis of femoral head |
| 04/26/2006 | CN1253178C Comminuted fracture treating bolus |